Triapine: Clinical Trials

17 trials of Triapine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 2 active not recruiting, 2 recruiting. 17 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 117Completed 13, Active not recruiting 2, Recruiting 2

Follow Triapine: new trials by email Literature Review of Triapine trials Research Report on Triapine

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Biospecimen Collection, Computed Tomography, Intensity-Modulated Radiation Therapy - Astrocytoma, IDH-Mutant, Grade 2, Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-Mutant
Phase 1RecruitingNational Cancer Institute (NCI)302025-07-302026-10-21
Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
Biospecimen Collection, Magnetic Resonance Imaging, Questionnaire Administration - Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma
Phase 1RecruitingNorthwestern University222024-07-232026-09-09
Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors
Biospecimen Collection, Computed Tomography, Lutetium Lu 177 Dotatate - Metastatic Digestive System Neuroendocrine Neoplasm, Metastatic Neuroendocrine Tumor
Phase 1Active not recruitingNational Cancer Institute (NCI)312020-07-202026-11-18
Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer
Biospecimen Collection, Brachytherapy, Cisplatin - Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma
Phase 1Active not recruitingNational Cancer Institute (NCI)212019-09-182026-11-18
3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery
3-Dimensional Conformal Radiation Therapy, Triapine - Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v6 and v7
Phase 1CompletedNational Cancer Institute (NCI)302006-12-202017-08-18
3-AP in Treating Patients With Advanced or Metastatic Solid Tumors
triapine, pharmacological study, laboratory biomarker analysis - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedNational Cancer Institute (NCI)242006-12-012013-12-16
3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
gemcitabine hydrochloride, triapine - Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma
Phase 1CompletedNational Cancer Institute (NCI)302006-06-012013-09-30
Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies
triapine, laboratory biomarker analysis, external beam radiation therapy - Recurrent Cervical Cancer, Recurrent Ovarian Epithelial Cancer
Phase 1CompletedNational Cancer Institute (NCI)242006-03-012013-01-11
Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors
triapine, irinotecan hydrochloride, laboratory biomarker analysis - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedNational Cancer Institute (NCI)362004-03-012013-05-16
3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome
fludarabine phosphate, triapine - Leukemia, Myelodysplastic Syndromes
Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins2004-01-012010-03-10
3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors
triapine, doxorubicin hydrochloride, laboratory biomarker analysis - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedNational Cancer Institute (NCI)362004-01-012013-05-16
3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies
cytarabine, triapine, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Phase 1CompletedNational Cancer Institute (NCI)482004-01-012013-01-24
3-AP and Cytarabine in Treating Patients With Hematologic Cancer
cytarabine, triapine - Leukemia, Myelodysplastic Syndromes
Phase 1CompletedVion Pharmaceuticals2003-03-012013-07-18
Combination Chemotherapy in Treating Patients With Advanced Cancer
cisplatin, triapine - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedVion Pharmaceuticals2001-03-012013-07-18
3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer
cisplatin, paclitaxel, triapine - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedVion Pharmaceuticals2000-12-012013-07-18
3-AP in Treating Patients With Advanced Cancer
triapine - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedVion Pharmaceuticals2000-05-012013-07-18
3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors
triapine - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedVion Pharmaceuticals1998-05-012013-07-18

Conditions studied

Precursor Cell Lymphoblastic Leukemia-Lymphoma (4)  ·  Blast Crisis (3)  ·  Congenital Abnormalities (3)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (3)  ·  Leukemia, Myeloid, Acute (3)  ·  Anemia, Refractory, with Excess of Blasts (2)  ·  Glioblastoma (2)  ·  Leukemia (2)  ·  Leukemia, Myeloid, Accelerated Phase (2)  ·  Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (2)  ·  Leukemia, Myelomonocytic, Chronic (2)  ·  Lymphoma, Follicular (2)  ·  Myelodysplastic Syndromes (2)  ·  Myelodysplastic-Myeloproliferative Diseases (2)  ·  Myeloproliferative Disorders (2)

Sponsors

National Cancer Institute (NCI) (10)  ·  Vion Pharmaceuticals (5)  ·  Northwestern University (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

Countries

United States (17)

Top investigators

Mario Sznol, MD (5)  ·  George Wilding (2)  ·  Tanios Bekaii-Saab (2)  ·  Charles Kunos (1)  ·  Judith E. Karp, MD (1)  ·  Karan Dixit, MD (1)  ·  Olatoyosi Odenike (1)  ·  Sarah E Taylor (1)  ·  Stephanie M Yoon (1)  ·  Susanne M Arnold (1)  ·  Yun Yen (1)

Results publications

PMID 17640728, PMID 27878356, PMID 39673591, PMID 42518206

NIH funding

U01CA062491 (2), U01CA076576 (2), P30CA006973 (1), P30CA014520 (1), P30CA016058 (1), P30CA060553 (1), U01CA062502 (1), U01CA062505 (1), U01CA069852 (1), U01CA070095 (1), UM1CA186690 (1), UM1CA186712 (1), UM1CA186717 (1)